Integrated pharmacokinetic-pharmacodynamic modeling and allometric scaling for optimizing the dosage regimen of the monoclonal ior EGF/r3 antibody. [electronic resource]
- European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences Feb 2004
- 261-70 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0928-0987
10.1016/j.ejps.2003.10.015 doi
Animals Antibodies, Monoclonal--administration & dosage Carcinoma, Non-Small-Cell Lung--metabolism Dose-Response Relationship, Drug ErbB Receptors--immunology Humans Injections, Intravenous Lung Neoplasms--metabolism Male Mice Mice, Nude Time Factors Xenograft Model Antitumor Assays--methods